Global Hemostats Market – Industry Trends - Forecast to 2026

  • General Surgery
  • Publish Reports
  • May 2019
  • Global
  • 278 Pages
  • No of Tables: 241
  • No of Figures: 237

Global Hemostats Market By Product Type (Thrombin Based, Combination, Oxidized Regenerated Cellulose Based, Gelatin Based, Collagen Based Hemostat), Formulation (Matrix & Gel Hemostats , Sheet & Pad Hemostats, Sponge Hemostats, Powder Hemostats), Application (Orthopedic, General Surgery, Neurological Surgery, Cardiovascular Surgery, Reconstructive Surgery, Gynecological Surgery), Indication (Wound Closure, Surgery), End-User (Hospitals, Clinics, Ambulatory Centers, Community Healthcare, Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends & Forecast to 2026

Market Analysis: Global Hemostats Market 

Global Hemostats Market is expected to rise from its initial estimated value of USD 3.06 billion in 2018 to an estimated value of USD 5.02 billion by 2026, registering a CAGR of 6.4% in the forecast period of 2019-2026. This rise in market value can be attributed to the rising number of surgical procedures.

Market Definition: Global Hemostats Market 

The hemostat can be defined as a surgical tool which is used to control blood loss or halt bleeding during major surgical. Basically it is used in early phases of surgery for an initial incision that closes blood vessels until ligation. It contain group of instruments which include needle holders, pivot, various clamps and various clamps.

According to the American Joint Replacement Surgery 2016, around 427,181 total surgical procedures were reported for joint replacement surgery in the U.S. However, the cluttering of surgical field due to multiple clamp attachment causing inconvenience to the surgeons and thus, leading to surgical errors is expected to hinder the market growth.

Market Drivers

  • Increasing healthcare expenditure and infrastructure, this significant act as driver to the market.
  • Increasing number of technological advancement, this significant act as driver to the market.

Market Restraints

  • Highly consolidated market, this act as restraints to the market.

Segmentation: Global Hemostats Market 

By Product Type

  • Thrombin Based
  • Combination
  • Oxidized Regenerated Cellulose Based
  • Gelatin Based
  • Collagen Based Hemostat

By Indication

  • Wound Closure
  • Surger

By Formulation

  • Matrix & Gel Hemostats
  • Sheet & Pad Hemostats
  • Sponge Hemostats
  • Powder Hemostats

By Application

  • Orthopedic Surgery
  • General Surgery
  • Neurological Surgery
  • Cardiovascular Surgery
  • Reconstructive Surgery
  • Gynecological Surgery

By End User

  • Hospitals
  • Clinics
  • Ambulatory Centers
  • Community Healthcare
  • Others

By Geography

  • North America

    • US.
    • Canada
    • Mexico

  • South America

    • Brazil
    • Argentina
    • Rest of South America

  • Europe

    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Turkey
    • Belgium
    • Netherlands
    • Switzerland
    • Rest of Europe

  • Asia-Pacific

    • Japan
    • China
    • South Korea
    • India
    • Australia
    • Singapore
    • Thailand
    • Malaysia
    • Indonesia
    • Philippines
    • Rest of Asia Pacific

  • Middle East & Africa

    • South Africa
    • Egypt
    • Saudi Arabia
    • United Arab Emirates
    • Israel
    • Rest of Middle East & Africa

Key Developments in the Market:

  • In April 2019, Biom’up announced that the U.S. Food and Drug Administration (FDA) approved the IDE (Investigational Device Exemption) application for HEMOSNOW, a hemostatic dry powder made from porcine collagen and bovine-derived chondroitin sulfate developed by the Company for managing minimal and mild levels of bleeding during surgical procedures.
  • In January 2019, Biom’up Company, specializing in surgical hemostasis announced that the U.S. Food and Drug Administration (FDA) has granted marketing approval for its HEMOBLAST Bellows Laparoscopic Applicator for all minimally-invasive procedures,

Competitive Analysis: Global Hemostats Market 

Global hemostats market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of hemostats market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Market Competitors: Global Hemostats Market 

Few of the major competitors currently working in the hemostats market are Ethicon US LLC (US), Baxter (US), Teleflex Incorporated (US), B. Braun Melsungen AG (Germany), 3-D Matrix Medical Technology (Japan), RESORBA Medical GmbH, Anika Therapeutics, Inc. (US), Arch Therapeutics, Inc. (US), Biom'up SAS, CryoLife, Inc. (US), Gamma Therapeutics, Inc. (US), Hemostasis, LLC. (USA), MedTrade Products Limited (UK), Integra LifeSciences (US), Medline Industries, Inc (US), HEMOTEC MEDICAL GMBH (Germany), Stryker (US), CSL (US), Mallinckrodt company. (UK), Equimedica (Europe), and others.

Research Methodology: Global Hemostats Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request an Analyst Call or can drop down your inquiry.

The key research methodology used by DBMR Research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Reasons to Purchase this Report

  • Current and future of global hemostats market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

  • All segmentation provided above in this report is represented at country level
  • All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

SKU-

TABLE OF CONTENTS :

1. INTRODUCTION

1.1. OBJECTIVES OF THE STUDY 1.2. MARKET DEFINITION 1.3. OVERVIEW OF GLOBAL HEMOSTATS MARKET 1.4. CURRENCY AND PRICING 1.5. LIMITATION 1.6. MARKETS COVERED

2. MARKET SEGMENTATION

2.1. MARKETS COVERED 2.2. GEOGRAPHIC SCOPE 2.3. YEARS CONSIDERED FOR THE STUDY 2.4. CURRENCY AND PRICING 2.5. RESEARCH METHODOLOGY 2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 2.7. SECONDARY SOURCE 2.8. ASSUMPTIONS

3. MARKET OVERVIEW

3.1. DRIVERS

3.1.1. CHRONIC CONDITIONS AND AGING POPULATION LEADING TO INCREASE IN NUMBER OF SURGICAL PROCEDURES 3.1.2. TECHNOLOGICAL ADVANCEMENTS 3.1.3. INCREASING NUMBER OF MINIMALLY INVASIVE SURGERIES 3.1.4. IMPROVING HEALTHCARE INFRASTRUCTURE AND INCREASING HEALTHCARE SPENDING

3.2. RESTRAINTS

3.2.1. RELUCTANCE OF SURGEONS TOWARDS NEW PRODUCTS 3.2.2. WEAK REIMBURSEMENT

3.3. OPPORTUNITIES

3.3.1. UNMET MEDICAL NEEDS 3.3.2. EMERGING MARKET

3.4. CHALLENGES

3.4.1. DEVELOPMENT OF SUBSTITUTE PRODUCTS 3.4.2. LIMITATIONS OF HEMOSTATIC AGENTS IN ACHIEVING HEMOSTASIS

4. PREMIUM INSIGHTS 5. REGULATORY

5.1. OVERVIEW 5.2. REGULATORY PROCEDURE

6. REIMBURSEMENT

6.1. OVERVIEW 6.2. REIMBURSEMENT SCENARIO

7. EXECUTIVE SUMMARY 8. GLOBAL HEMOSTATS MARKET, BY TYPE

8.1. OVERVIEW 8.2. THROMBIN BASED HEMOSTATS 8.3. COMBINATION AGENT HEMOSTATS 8.4. OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS 8.5. GELATIN BASED HEMOSTATS 8.6. COLLAGEN BASED HEMOSTATS

9. GLOBAL HEMOSTATS MARKET,BY APPLICATION

9.1. OVERVIEW 9.2. GLOBAL HEMOSTATS MARKET, BY APPLICATION 9.3. WOUND CLOSURE 9.4. SURGICAL HEMOSTATS

10. GLOBAL HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL

10.1. OVERVIEW 10.1.1. DIRECT TENDERS 10.1.2. RETAIL

11. GLOBAL HEMOSTATS MARKET, BY END USER

11.1. OVERVIEW 11.2. HOSPITALS 11.3. AMBULATORY CENTERS 11.4. COMMUNITY HEALTHCARE 11.5. CLINICS

12. GLOBAL HEMOSTATS MARKET, BY GEOGRAPHY

12.1. OVERVIEW

12.2. NORTH AMERICA

12.2.1. U.S. 12.2.2. CANADA 12.2.3. MEXICO

12.3. EUROPE

12.3.1. GERMANY 12.3.2. FRANCE 12.3.3. U.K. 12.3.4. ITALY 12.3.5. SPAIN 12.3.6. RUSSIA 12.3.7. TURKEY 12.3.8. BELGIUM 12.3.9. NETHERLANDS 12.3.10. SWITZERLAND 12.3.11. REST OF EUROPE

12.4. ASIA-PACIFIC (APAC)

12.4.1. JAPAN 12.4.2. CHINA 12.4.3. SOUTH KOREA 12.4.4. INDIA 12.4.5. AUSTRALIA 12.4.6. SINGAPORE 12.4.7. THAILAND 12.4.8. MALAYSIA 12.4.9. INDONESIA 12.4.10. PHILIPPINES 12.4.11. REST OF APAC

12.5. SOUTH AMERICA

12.5.1. BRAZIL 12.5.2. REST OF SOUTH AMERICA

12.6. MEA

12.6.1. SOUTH AFRICA 12.6.2. REST OF MEA

13. GLOBAL HEMOSTATS MARKET, COMPANY LANDSCAPE

13.1. COMPANY SHARE ANALYSIS: GLOBAL 13.2. COMPANY SHARE ANALYSIS: NORTH AMERICA 13.3. COMPANY SHARE ANALYSIS: EUROPE 13.4. COMPANY SHARE ANALYSIS: APAC

14. COMPANY PROFILES

14.1. ETHICON US, LLC (SUBSIDIARY OF JOHNSON & JOHNSON SERVICES, INC)

14.1.1. COMPANY OVERVIEW 14.1.2. REVENUE ANALYSIS 14.1.3. PRODUCT PORTFOLIO 14.1.4. RECENT DEVELOPMENTS

14.2. PFIZER

14.2.1. COMPANY OVERVIEW 14.2.2. REVENUE ANALYSIS 14.2.3. PRODUCT PORTFOLIO 14.2.4. RECENT DEVELOPMENTS

14.3. C.R BARD

14.3.1. COMPANY OVERVIEW 14.3.2. REVENUE ANALYSIS 14.3.3. PRODUCT PORTFOLIO 14.3.4. RECENT DEVELOPMENTS

14.4. BAXTER

14.4.1. COMPANY OVERVIEW 14.4.2. REVENUE ANALYSIS 14.4.3. PRODUCT PORTFOLIO 14.4.4. RECENT DEVELOPMENTS

14.5. VASCULAR SOLUTIONS, INC (ACQUIRED BY TELEFLEX INCORPORATED)

14.5.1. COMPANY OVERVIEW 14.5.2. REVENUE ANALYSIS 14.5.3. PRODUCT PORTFOLIO 14.5.4. RECENT DEVELOPMENTS

14.6. B.BRAUN MELSUNGEN AG

14.6.1. COMPANY OVERVIEW 14.6.2. REVENUE ANALYSIS 14.6.3. PRODUCT PORTFOLIO 14.6.4. RECENT DEVELOPMENTS

14.7. 3-D MATRIX LTD

14.7.1. COMPANY OVERVIEW 14.7.2. REVENUE ANALYSIS 14.7.3. PRODUCT PORTFOLIO 14.7.4. RECENT DEVELOPMENTS

14.8. RESORBA MEDICAL GMBH

14.8.1. COMPANY OVERVIEW 14.8.2. REVENUE ANALYSIS 14.8.3. PRODUCT PORTFOLIO 14.8.4. RECENT DEVELOPMENTS

14.9. ANIKA THERAPEUTICS, INC.

14.9.1. COMPANY OVERVIEW 14.9.2. REVENUE ANALYSIS 14.9.3. PRODUCT PORTFOLIO 14.9.4. RECENT DEVELOPMENTS

14.10. BIOM’UP

14.10.1. COMPANY OVERVIEW 14.10.2. REVENUE ANALYSIS 14.10.3. PRODUCT PORTFOLIO 14.10.4. RECENT DEVELOPMENTS

14.11. CRYOLIFE, INC.

14.11.1. COMPANY OVERVIEW 14.11.2. REVENUE ANALYSIS 14.11.3. PRODUCT PORTFOLIO 14.11.4. RECENT DEVELOPMENTS

14.12. EQUIMEDICAL

14.12.1. COMPANY OVERVIEW 14.12.2. REVENUE ANALYSIS 14.12.3. PRODUCT PORTFOLIO 14.12.4. RECENT DEVELOPMENTS

14.13. HEMOSTASIS, LLC

14.13.1. COMPANY OVERVIEW 14.13.2. REVENUE ANALYSIS 14.13.3. PRODUCT PORTFOLIO 14.13.4. RECENT DEVELOPMENTS

14.14. MEDTRADE PRODUCTS LIMITED

14.14.1. COMPANY OVERVIEW 14.14.2. REVENUE ANALYSIS 14.14.3. PRODUCT PORTFOLIO 14.14.4. RECENT DEVELOPMENTS

14.15. STRYKER

14.15.1. COMPANY OVERVIEW 14.15.2. REVENUE ANALYSIS 14.15.3. PRODUCT PORTFOLIO 14.15.4. RECENT DEVELOPMENTS

14.16. ARCH THERAPEUTICS, INC.

14.16.1. COMPANY OVERVIEW 14.16.2. REVENUE ANALYSIS 14.16.3. PRODUCT PORTFOLIO 14.16.4. RECENT DEVELOPMENTS

14.17. INTEGRA LIFESCIENCES CORPORATION

14.17.1. COMPANY OVERVIEW 14.17.2. REVENUE ANALYSIS 14.17.3. PRODUCT PORTFOLIO 14.17.4. RECENT DEVELOPMENTS

14.18. ALTAYLAR MEDICAL

14.18.1. COMPANY OVERVIEW 14.18.2. REVENUE ANALYSIS 14.18.3. PRODUCT PORTFOLIO 14.18.4. RECENT DEVELOPMENTS

14.19. BIOCER ENTWICKLUNGS-GMBH

14.19.1. COMPANY OVERVIEW 14.19.2. REVENUE ANALYSIS 14.19.3. PRODUCT PORTFOLIO 14.19.4. RECENT DEVELOPMENTS

14.20. SMI (STARCH MEDICAL)

14.20.1. COMPANY OVERVIEW 14.20.2. REVENUE ANALYSIS 14.20.3. PRODUCT PORTFOLIO 14.20.4. RECENT DEVELOPMENTS

15. RELATED REPORTS

LIST OF TABLE :

TABLE 1 HEALTHCARE EXPENDITURES OF VARIOUS COUNTRIES TABLE 2 ABSORBABLE HEMOSTATIC AGENTS APPROVED THROUGH PMA OR NDA* TABLE 3 GLOBAL HEMOSTATS MARKET, BY PRODUCT TYPE, BY REGION 2015– 2024 (USD MILLION) TABLE 4 GLOBAL HEMOSTATS MARKET, BY TYPE, 2015 – 2024(USD MILLION) TABLE 5 GLOBAL HEMOSTATS MARKET, THROMBIN BASED, BY REGION 2015– 2024 (USD MILLION) TABLE 6 GLOBAL HEMOSTATS MARKET, COMBINATION AGENT, BY REGION 2015– 2024 (USD MILLION) TABLE 7 GLOBAL HEMOSTATS MARKET, OXIDIZED REGENERATED CELLULOSE BASED, BY REGION, 2015– 2024 (USD MILLION) TABLE 8 GLOBAL HEMOSTATS MARKET, GELATIN BASED, BY REGION 2015– 2024 (USD MILLION) TABLE 9 GLOBAL HEMOSTATS MARKET, COLLAGEN BASED, BY REGION 2015– 2024 (USD MILLION) TABLE 10 GLOBAL HEMOSTATS APPLICATION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 11 WOUND CLOSURE, BY APPLICATION, BY REGION, 2015 – 2024 (USD MILLION) TABLE 12 SURGICAL HEMOSTATS, BY APPLICATION, BY REGION, 2015 – 2024 (USD MILLION) TABLE 13 GLOBAL HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 14 GLOBAL HEMOSTATS MARKET, DIRECT TENDERS, BY REGION, 2015 – 2024 (USD MILLION) TABLE 15 GLOBAL HEMOSTATS MARKET, RETAIL, BY REGION, 2015 – 2024 (USD MILLION) TABLE 16 GLOBAL HEMOSTATS MARKET, BY END USER, 2015– 2024 (USD MILLION) TABLE 17 GLOBAL HEMOSTATS MARKET, HOSPITALS, BY REGION 2015– 2024 (USD MILLION) TABLE 18 GLOBAL HEMOSTATS MARKET, AMBULATORY CENTERS, BY REGION 2015– 2024 (USD MILLION) TABLE 19 GLOBAL HEMOSTATS MARKET, COMMUNITY HEALTHCARE, BY REGION 2015– 2024 (USD MILLION) TABLE 20 GLOBAL HEMOSTATS MARKET, CLINICS, BY REGION 2015– 2024 (USD MILLION) TABLE 21 GLOBAL HEMOSTATS MARKET, BY GEOGRAPHY, 2015 – 2024 (USD MILLION) TABLE 22 NORTH AMERICA HEMOSTATSMARKET, BY COUNTRY, 2015 – 2024 (USD MILLION) TABLE 23 NORTH AMERICA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 24 NORTH AMERICA HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 25 NORTH AMERICA HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 26 NORTH AMERICA HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 27 U.S. HEMOSTATS MARKET, BY PRODUCT TYPE ,2015 – 2024 (USD MILLION) TABLE 28 U.S. HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 29 U.S.HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 30 U.S. HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 31 CANADA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 32 CANADA HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 33 CANADA HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 34 CANADA HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 35 MEXICO HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024(USD MILLION) TABLE 36 MEXICO HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 37 MEXICO HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 38 MEXICO HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 39 EUROPE HEMOSTATS S MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION) TABLE 40 EUROPEHEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024(USD MILLION) TABLE 41 EUROPE HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 42 EUROPE HEMOSTATS MARKET, BY END USER,2015 – 2024 (USD MILLION) TABLE 43 EUROPE HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 44 GERMANYHEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024(USD MILLION) TABLE 45 GERMANY HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 46 GERMANY HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 47 GERMANY HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 48 FRANCE HEMOSTATS MARKET, BY PRODUCT TYPE,2015 – 2024(USD MILLION) TABLE 49 FRANCE HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 50 FRANCE HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 51 FRANCE HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 52 U.K. HEMOSTATS MARKET, BY PRODUCT TYPE,2015 – 2024(USD MILLION) TABLE 53 U.K. HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 54 U.K. HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 55 U.K. HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 56 ITALY HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 57 ITALY HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 58 ITALY HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 59 ITALY HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 60 SPAIN HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 61 SPAIN HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 62 SPAIN HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 63 SPAIN HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 64 RUSSIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 65 RUSSIA HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 66 RUSSIA HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 67 RUSSIA HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 68 TURKEY HEMOSTATS MARKET, BY PRODUCT TYPE,2015 – 2024(USD MILLION) TABLE 69 TURKEY HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 70 TURKEY HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 71 TURKEY HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 72 BELGIUM HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 73 BELGIUM HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 74 BELGIUM HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 75 BELGIUM HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 76 NETHERLANDS HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 77 NETHERLANDS HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 78 NETHERLANDS HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 79 NETHERLANDS HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 80 SWITZERLAND HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 81 SWITZERLAND HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 82 SWITZERLAND HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 83 SWITZERLAND HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 84 REST OF EUROPE HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 85 APAC HEMOSTATS S MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION) TABLE 86 APAC HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 87 APAC HEMOSTATS MARKET, BY APPLICATION,2015 – 2024 (USD MILLION) TABLE 88 APAC HEMOSTATS MARKET, BY END USER,2015 – 2024 (USD MILLION) TABLE 89 APAC HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 90 JAPAN HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 91 JAPAN HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 92 JAPAN HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 93 JAPAN HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 94 CHINA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 95 CHINA HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 96 CHINA HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 97 CHINA HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 98 SOUTH KOREAHEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024(USD MILLION) TABLE 99 SOUTH KOREA HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 100 SOUTH KOREA HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 101 SOUTH KOREA HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 102 INDIA HEMOSTATS MARKET, BY PRODUCT TYPE,2015 – 2024(USD MILLION) TABLE 103 INDIA HEMOSTATS MARKET, BY APPLICATION,2015 – 2024 (USD MILLION) TABLE 104 INDIA HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 105 INDIA HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 106 AUSTRALIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 107 AUSTRALIA HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 108 AUSTRALIA HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 109 AUSTRALIA HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 110 SINGAPORE HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 111 SINGAPORE HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 112 SINGAPORE HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 113 SINGAPORE HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 114 THAILAND HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 115 THAILAND HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 116 THAILAND HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 117 THAILAND HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 118 MALAYSIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 119 MALAYSIA HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 120 MALAYSIA HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 121 MALAYSIA HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 122 INDONESIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 123 INDONESIA HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 124 INDONESIA HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 125 INDONESIA HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 126 PHILIPPINES HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 127 PHILIPPINES HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 128 PHILIPPINES HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 129 PHILIPPINES HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 130 REST OF APACHEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024(USD MILLION) TABLE 131 SOUTH AMERICAHEMOSTATS S MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION) TABLE 132 SOUTH AMERICA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 133 SOUTH AMERICA HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 134 SOUTH AMERICA HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 135 SOUTH AMERICA HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 136 BRAZIL HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 137 BRAZIL HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 138 BRAZIL HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 139 BRAZIL HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 140 REST OF SOUTH AMERICA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 141 MEA HEMOSTATS MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION) TABLE 142 MEA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 143 MEA HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 144 MEA HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 145 MEA HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 146 SOUTH AFRICAHEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 147 SOUTH AFRICA HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 148 SOUTH AFRICA HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 149 SOUTH AFRICA HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 150 REST OF MEA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)

LIST OF FIGURES

FIGURE 1 GLOBAL HEMOSTATS MARKET: SEGMENTATION FIGURE 2 GLOBAL HEMOSTATS MARKET: GEOGRAPHIC SCOPE FIGURE 3 GLOBAL HEMOSTATS MARKET: DATA TRIANGULATION FIGURE 4 GLOBAL HEMOSTATS MARKET RESEARCH SNAPSHOT FIGURE 5 GLOBAL HEMOSTATS MARKET BOTTOM UP APPROACH FIGURE 6 GLOBAL HEMOSTATS MARKET TOP DOWN APPROACH FIGURE 7 GLOBAL HEMOSTATS MARKET: INTERVIEW DEMOGRAPHICS FIGURE 8 MEDICAL ADVANCEMENTS AND INCREASE IN HEMORRAGE CASES ARE EXPECTED TO DRIVE THE MARKET FOR HEMOSTATS IN THE FORECAST PERIOD 2017 TO 2024 FIGURE 9 THROMBIN BASED HEMOSTATS MARKET SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE HEMOSTATS MARKET IN 2017 & 2024 FIGURE 10 ASIA PACIFIC IS THE HIGHEST GROWING AND MOST PROFITABLE REVENUE POCKETS FOR HEMOSTATS MANUFACTURERS IN THE FORECAST PERIOD TO 2024 FIGURE 11 GLOBAL HEMOSTATS MARKET: SEGMENTATION FIGURE 12 NORTH AMERICA IS EXPECTED TO DOMINATE THE MARKET FOR HEMOSTATS AND APAC IS EXPECTED TO BE GROWING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD TO 2024 FIGURE 13 GLOBAL HEMOSTATS MARKET: BY TYPE, SNAPSHOT 2016 FIGURE 14 GLOBAL THROMBIN BASED HEMOSTATS MARKET: BY REGION FIGURE 15 GLOBAL COMBINATION AGENT HEMOSTATS MARKET: BY REGION FIGURE 16 GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET: BY REGION FIGURE 17 GLOBAL GELATIN BASED HEMOSTATS MARKET: BY REGION FIGURE 18 GLOBAL COLLAGEN BASED HEMOSTATS MARKET: BY REGION FIGURE 19 GLOBAL HEMOSTATS MARKET: BY APPLICATION, SNAPSHOT 2016 FIGURE 20 GLOBAL HEMOSTATS MARKET: WOUND CLOSURE, BY REGION FIGURE 21 GLOBAL HEMOSTATS MARKET: SURGERIES, BY REGION FIGURE 22 GLOBAL HEMOSTATS MARKET: BY DISTRIBUTION CHANNEL, SNAPSHOT 2016 FIGURE 23 GLOBAL HEMOSTATS MARKET: DIRECT TENDERS, BY REGION FIGURE 24 GLOBAL HEMOSTATS MARKET: RETAIL, BY REGION FIGURE 25 GLOBAL HEMOSTATS MARKET DOMINATED BY HOSPITALS FIGURE 26 GLOBAL HEMOSTATS MARKET:BY END-USER, SNAPSHOT 2016 FIGURE 27 GLOBAL HEMOSTATS MARKET: HOSPITALS; BY REGION FIGURE 28 GLOBAL HEMOSTATS MARKET: AMBULATORY CENTERS; BY REGION FIGURE 29 GLOBAL HEMOSTATS MARKET: COMMUNITY HEALTHCARE; BY REGION FIGURE 30 GLOBAL HEMOSTATS MARKET: CLINICS; BY REGION FIGURE 31 GLOBAL HEMOSTATS MARKET SNAPSHOT (2017) FIGURE 32 GLOBAL HEMOSTATS MARKET: BY GEOGRAPHY (2016) FIGURE 33 GLOBAL HEMOSTATS MARKET :BY COUNTRY (2017) FIGURE 34 GLOBAL HEMOSTATS MARKET BY COUNTRY (2016 & 2024) FIGURE 35 GLOBAL HEMOSTATS MARKET BY PRODUCT TYPE (2017 & 2024) FIGURE 36 NORTH AMERICA HEMOSTATS MARKET SNAPSHOT (2017) FIGURE 37 NORTH AMERICA HEMOSTATS MARKET: BY GEOGRAPHY (2016) FIGURE 38 NORTH AMERICA HEMOSTATSMARKET :BY COUNTRY (2017) FIGURE 39 NORTH AMERICA HEMOSTATS MARKET BY COUNTRY (2016 & 2024) FIGURE 40 NORTH AMERICA HEMOSTATS MARKET BY PRODUCT TYPE (2017 & 2024 FIGURE 41 EUROPE HEMOSTATS MARKET SNAPSHOT (2017) FIGURE 42 EUROPE HEMOSTATS MARKET: BY GEOGRAPHY (2016) FIGURE 43 EUROPE HEMOSTATS MARKET :BY COUNTRY (2017) FIGURE 44 EUROPE HEMOSTATS MARKET BY COUNTRY (2016 & 2024) FIGURE 45 EUROPE HEMOSTATS MARKET BY PRODUCT TYPE (2017 & 2024) FIGURE 46 APAC HEMOSTATS MARKET SNAPSHOT (2017) FIGURE 47 APAC HEMOSTATS MARKET: BY GEOGRAPHY (2016) FIGURE 48 APAC HEMOSTATS MARKET :BY COUNTRY (2017) FIGURE 49 APAC HEMOSTATS MARKET BY COUNTRY (2016 & 2024) FIGURE 50 APAC HEMOSTATS MARKET BY PRODUCT TYPE (2017 & 2024) FIGURE 51 SOUTH AMERICAHEMOSTATS MARKET SNAPSHOT (2017) FIGURE 52 SOUTH AMERICA HEMOSTATS MARKET: BY GEOGRAPHY (2016) FIGURE 53 SOUTH AMERICA HEMOSTATS MARKET :BY COUNTRY (2017) FIGURE 54 SOUTH AMERICAHEMOSTATS MARKET BY COUNTRY (2016 & 2024) FIGURE 55 SOUTH AMERICAHEMOSTATS MARKET BY PRODUCT TYPE (2017 & 2024) FIGURE 56 MEA HEMOSTATS MARKET SNAPSHOT (2017) FIGURE 57 MEA HEMOSTATS MARKET: BY GEOGRAPHY (2016) FIGURE 58 MEA HEMOSTATS MARKET :BY COUNTRY (2017) FIGURE 59 MEA HEMOSTATS MARKET BY COUNTRY (2016 & 2024) FIGURE 60 MEA HEMOSTATS MARKET BY PRODUCT TYPE (2017 & 2024) FIGURE 61 GLOBAL HEMOSTATS MARKET: COMPANY SHARE 2016 (%) FIGURE 62 NORTH AMERICA HEMOSTATS MARKET: COMPANY SHARE 2016 (%) FIGURE 63 EUROPE HEMOSTATS MARKET: COMPANY SHARE 2016 (%) FIGURE 64 APAC HEMOSTATS MARKET: COMPANY SHARE 2016 (%)

Please fill in the below form for detailed Inquire Before Buying

Choose License Type
  • $5400.00
  • $4200.00
BUY NOW ADD TO CART